Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.

AI/ML

Health Care

Nucleai

Avi Veidman

Iris Klein

Mor Golan

Meitar Gdalyahu

Aviv Levi

Hagar Sachs

Ken Bloom

Neelima Kumar

Jonathan Daniels

Lotan Chorev

Vikas Ahuja

Oscar Puig

Pinchas Birnbaum

Shiri Amir

Alon Lekhtman

Zehavit Rachmiel Arison

Gon Yishay

Yaniv Roth

Shani Caspi

Shai Bookstein

Roni Yichie

Ron Elran

Mor Matalon

Lauren Alaluf

Keren Uritsky Gur

Efrat Dicker Sagy

Romi Sadan

Rakefet Rosenstock

Paz Benchetrit

Yoad Cohen

Shir Rosen Zvi

Omer Asyas

Ofek Arviv

Luba Ilfeld

Liza Potikha

Rivka Becky A.

Madhav Reddy

Liat Ben-Senior MBA MSc

Golan Mizrahi

Ettai Markovits

Eliron Amir

Albert Achtenberg

The Product Development team at Nucleai focuses on designing, refining, and advancing the AI-powered platform for spatial biology. They collaborate closely with pharmaceutical partners to customize the platform for specific research needs, ensure seamless integration of unique tissue datasets, and identify new biomarkers to enhance drug development and patient outcomes.

Product Development

Medical Data Team

Data Science Team

Directors

Product Development

About

Team members

Other teams at Nucleai

Medical Data Team

Data Science Team

Directors